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Abstract
Background: Kruppel-like factor KLF4 is a transcription factor critical for the establishment of the barrier function of the skin.
Its function in stem cell biology has been recently recognized. Previous studies have revealed that hair follicle stem cells
contribute to cutaneous wound healing. However, expression of KLF4 in hair follicle stem cells and the importance of such
expression in cutaneous wound healing have not been investigated.
Methodology/Principal Findings: Quantitative real time polymerase chain reaction (RT-PCR) analysis showed higher KLF4
expression in hair follicle stem cell-enriched mouse skin keratinocytes than that in control keratinocytes. We generated KLF4
promoter-driven enhanced green fluorescence protein (KLF4/EGFP) transgenic mice and tamoxifen-inducible KLF4
knockout mice by crossing KLF4 promoter-driven Cre recombinase fused with tamoxifen-inducible estrogen receptor (KLF4/
CreER
TM) transgenic mice with KLF4(flox) mice. KLF4/EGFP cells purified from dorsal skin keratinocytes of KLF4/EGFP
transgenic mice were co-localized with 5-bromo-2’-deoxyuridine (BrdU)-label retaining cells by flow cytometric analysis and
immunohistochemistry. Lineage tracing was performed in the context of cutaneous wound healing, using KLF4/CreER
TM
and Rosa26RLacZ double transgenic mice, to examine the involvement of KLF4 in wound healing. We found that KLF4
expressing cells were likely derived from bulge stem cells. In addition, KLF4 expressing multipotent cells migrated to the
wound and contributed to the wound healing. After knocking out KLF4 by tamoxifen induction of KLF4/CreER
TM and
KLF4(flox) double transgenic mice, we found that the population of bulge stem cell-enriched population was decreased,
which was accompanied by significantly delayed cutaneous wound healing. Consistently, KLF4 knockdown by KLF4-specific
small hairpin RNA in human A431 epidermoid carcinoma cells decreased the stem cell population and was accompanied by
compromised cell migration.
Conclusions/Significance: KLF4 expression in mouse hair bulge stem cells plays an important role in cutaneous wound
healing. These findings may enable future development of KLF4-based therapeutic strategies aimed at accelerating
cutaneous wound closure.
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Introduction
Skin is a continuously regenerating organ composed of a basal
layer of proliferating cells and suprabasal layers of terminally
differentiating cells that transit toward and are sloughed from skin
surface [1]. Epidermal renewal is thought to be controlled by stem
cells located either in the basal layer of the interfollicular epidermis
(IFE) or in the deepest portion of permanent hair follicle called
bulge [2]. Mouse hair follicle stem cells which reside in the hair
follicle bulge are characterized by expression of CD34 cell-surface
marker [3,4,5], retention of either DNA or histone labels over long
periods [6,7], and expression of Leucine-rich repeats and
immunoglobin-like domain protein 1 (Lrig1) [8,9]. It has been
shown that expression of CD49f, which is also known as a6
integrin, was continuous throughout the basal layer of IFE and
hair follicles [10]. Wound healing is an important response of skin
that repairs itself after injury. Regeneration of epidermis after
wounding involves activation, migration and proliferation of
keratinocytes from both the surrounding epidermis and the
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39663adnexal structures such as hair follicles [11,12,13]. The discovery
of properties of epidermal stem cells led to the hypothesis that
these stem cells play a critical role in epidermal repair after
wounding. Previous work has reported that bulge stem cells
rapidly respond to wounding and migrate towards the IFE to help
with the rapid hair-follicle regeneration and that bulge-derived
cells are transient amplifying cells committed to differentiation
[9,12,14]. However, the role and contribution of keratinocytes
derived from hair follicle bulge stem cells to cutaneous wound
healing need further elucidation.
Kruppel like factor 4 (KLF4) is a transcriptional factor
previously known as gut-enriched Kruppel-like factor. As a mem-
ber of Kruppel-like factor family, KLF4 is highly expressed in the
gastrointestinal tract and other epithelial tissues including skin
[15,16]. KLF4 has been thoroughly investigated with respect to its
role in cell cycle arrest and cellular differentiation
[17,18,19,20,21]. Previous work has shown that KLF4 is required
for establishing the barrier function of skin. KLF4 null mice die
shortly after birth due to loss of skin barrier function without
morphological and biochemical alterations. Instead, knockout of
KLF4 selectively perturbs the differentiation of late-stage struc-
tures, including the cornified envelope [1]. Recently, KLF4 has
been shown to have key functions in stem cell biology. Gene
profiling results showed that KLF4 expression was elevated in
mammary gland stem cells [22] and in hematopoietic stem cells
[23,24,25]. Forced expression of KLF4 was found to inhibit
embryonic stem cell differentiation and increase their self-renewal
capacity [26,27]. In addition, KLF4, together with three other
transcription factors, Oct4, Sox2, and c-Myc, transformed mouse
embryonic and adult fibroblasts into induced pluripotent stem cells
[28]. We recently found that KLF4 is required for the
maintenance of breast cancer stem cells [29]. These observations
suggest that KLF4 plays an indispensable role in the maintenance
of stem cells. However, expression of KLF4 in epidermal stem cells
and its potential function in cutaneous wound healing have not
been investigated.
In this study, we showed that KLF4 is likely expressed in mouse
epidermal stem cells. A decreased number of hair bulge stem cells
was observed in KLF4 knockout mice, which was accompanied by
decreased ability of colony formation from these cells when
compared to those from control mice, suggesting that KLF4 may
be required for the maintenance of skin hair follicle stem cells.
Notably, KLF4 deficiency delayed the process of mouse cutaneous
wound healing, during which process KLF4-expressing multi-
potent cells migrated towards the wound area.
Materials and Methods
Ethics statement
The study has been approved by the Institutional Biosafety
Committee (IBC) and by the Institutional Animal Care and Use
Committees (IACUC) of University of South Carolina (Proposal
number 1867).
Purification of mouse dorsal skin keratinocytes, flow
cytometry, and cell sorting
Purification of mouse dorsal skin keratinocytes was performed as
reported previously [30,31]. They were collected and resuspended
at 1 million cells per ml in PBS with 0.5% BSA and then stained
with PE-conjugated antibody to CD49f, APC-conjugated antibody
to Lrig1, FITC or Percp-Cy5.5-conjugated antibody to CD34
(eBioscience) for 1 h on ice. Staining analysis was carried out by
using a flow cytometer (Cytomics FC 500; Beckman Coulter). Cell
sorting was performed using the FACSAria cell sorter (BD
Biosciences).
RNA extraction and quantitative RT-PCR analysis
Total RNA was prepared using Trizol Reagent (Invitrogen)
according to the manufacturer’s instructions. First-strand cDNA
synthesis was performed using Oligo (dT) and Superscript III
reverse transcriptase (Invitrogen). Real-time PCR was performed
as described previously [32]. Quantitative real-time PCR primer
sequences were listed in Table 1.
Generation of the KLF4/EGFP transgenic mouse model
PKD4-NICD-EGFP plasmid (a kind gift from Dr. Andrew
Leiter at University of Massachusetts) was used as PCR templates
to amplify fragments containing EGFP. Bacterial artificial
chromosome (BAC) clone # RP23-322L22 was obtained from
Children’s Hospital Oakland Research Institute (CHORI) and the
bac clone was then introduced into a bacterial strain BL250
(kindly provided by Dr. Neal G. Copeland at NIH). BL250
bacteria containing RP23-322L22 were made competent and
transformed with the amplified EGFP fragment by electroporation
according to a previous report [33]. Clones in which the amplified
fragment was inserted via homologous recombination were
selected using resistance to chloramphenicol and kanamycin.
Selected colonies were screened for correct recombination by
amplification using EGFP- specific primers. The FRT-flanked
kanamycin resistant (KANA) gene was excised from KLF4/EGFP-
KANA BAC clones by expressing the FLP recombinase. A
diagram of the construction strategy to generate a KLF4/EGFP
transgene is shown in Figure S1A. Clamped homogenous electric
fields (CHEF) gel electrophoresis and DNA sequencing confirmed
correct transgene constructions and integrity of the BAC flanking
sequence. The KLF4/EGFP BAC was then purified for pro-
nuclear microinjection. Potential founder mice (B6/CBA mixed
background) were genotyped by tail DNA amplification using
primers specific for the EGFP coding sequence. The founder
transgenic mice were then backcrossed 6–8 generations to obtain
the pure C57BL/6 background. The KLF4/CreER
TM transgenic
model using a construct containing Cre recombinase cDNA fused
with a tamoxifen-inducible (TM) estrogen receptor (ER) gene (a
plasmid kindly provided by Dr. Douglas Melton at Harvard
Medical School) as the transgene was similarly generated [34].
KLF4 (flox+/+) mouse model was generated as described [35].
Immunohistochemistry (IHC)
Following sacrifice, skin tissues were dissected, embedded in
paraffin and sectioned at 4 mm. IHC was performed using
a standard protocol. Signal was detected using the KPL’s 3,3-
Diaminobenzidine (DAB) Reagent Set (KPL, Gaithersburg, MD)
according to the manufacturer’s instructions, and counterstaining
was carried out with Mayer hematoxylin. The following primary
antibodies were used: rabbit anti-KLF4 monoclonal antibody
(1:500, Genespin, Milano, Italy), rabbit anti-Ki67 antibody (1:500,
Abcam), rat anti-BrdU antibody (1:100, AbD serotec, Oxford,
UK).
X-gal staining of KLF4/CreER
TM and Rosa26RLac Z double
transgenic mice
Freshly obtained mouse dorsal skin with or without wound
placement were fixed with 4% paraformaldehyde for 6 hours
followed by 30% sucrose overnight. The samples were embedded
in OCT and sectioned at 10 mm. To detect b-Galactosidase
activity, frozen sections were washed 3 times for 5 min with rinse
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a solution consisting of 1 mg/ml X-gal, 5 mM ferrothiocyanide
and 5 mM ferrithiocyanide in rinse buffer. The slides were stained
with fast red with or without xylene treatment before being
photographed under a microscope.
Colony formation assay
Primary keratinocytes purified from mouse dorsal skin were
seeded at 2610
3 cells per 60-mm dish on 3T3 feeder layer. The
growth medium was changed every other day. Sixteen days later,
cells were fixed with PBS-buffered 4% formaldehyde and stained
with 0.5% rhodamine B (Sigma) to visualize the keratinocyte
colonies. Three independent experiments were conducted and
analyzed.
BrdU labeling, induction of KLF4 knockout and
placement of mouse dorsal wounds
Mice were housed in micro-isolator; solid-bottomed polycarbo-
nate cages under a pathogen free condition and experiments were
approved by the Institutional Animal Care and Use Committees of
University of South Carolina. Three-day-old KLF4/EGFP mice
were injected intraperitoneally with BrdU (75mg/kg) once a day
for five consecutive days. Mice were maintained for three months
after final BrdU injection to trace LRC. Cre recombinase was
induced by daily intraperitoneal injection of tamoxifen (100mg/
kg) or topical application of 4-hydroxyl-tamoxifen (1mg/0.2ml
acetone) (Sigma, St Louis, MO) for 5 consecutive days. In vivo
wound healing study was performed after indicated induction. The
backs of the mice were shaved and sterilized with 1% iodine
solution followed by alcohol. Two full thickness wounds in parallel
were made using a dermal biopsy punch of 8mm or 5mm in
diameter [36]. After wound placement, mice were housed
separately and wounds were observed and photographed on days
1, 5, and 10. The wound closure was determined by the
convergence of circular skin edges after wound placement.
Generation of KLF4 knockdown and overexpression
stable cell lines
Human epidermoid carcinoma cell line A431 cells were
purchased from ATCC and cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM
L-glutamine at 37uC in a humidified atmosphere of 5% CO2.T o
generate stable cell lines, plasmids containing KLF4 specific
shRNA (pRetroSuper-KLF4#2, designated as shKLF4) or the
control vector (pRetroSuper, designated as siCon) [37] and KLF4
overexpression vector (pBabePuro-DN KLF4, designated as
KLF4-N) and the control vector (pBabePuro, designated as Con)
kindly provided by Daniel S. Peeper at Netherlands Cancer
Institute, and were transfected into A431 cells using Lipofectami-
ne
TM 2000. 48 h after transfection, cells were trypsinized and
reseeded into 10-cm culture plates. Cells were selected with
puromycin at a final concentration of 2mg/ml for 3 weeks. Single
colonies were selected, confirmed, and expanded for the sub-
sequent experiments.
Protein extraction and Western Blotting analysis
Total proteins from culture cells were prepared using radio-
immunoprecipitation assay (RIPA) buffer, and 50mg of proteins
were separated by 12% SDS-PAGE gel followed by Western
blotting analysis as previously described [32]. The antibodies used
were: rabbit monoclonal anti-KLF4 (1:1500), anti-p21 (1:1000),
and anti-a-Tubulin (1:4000, Santa Cruz Biotechnology).
In vitro scratch assay
A431 cells were cultured to full confluence, and then the
medium was changed to DMEM with 0.5% FBS 2h before
scratching. The scratch was performed by a 200 ml pipette tip.
The detached cells were removed and the remaining cells
incubated in DMEM with 0.5% FBS [38]. 12 h later, plates were
imaged under Nikon microscope using a 106 Phase contrast
objective.
Statistical analysis
Two-way ANOVA and two-tailed t-tests were employed to
analyze data using Prism 5.0 software (GraphPad). P,0.05 was
defined as statistically significant.
Results
Expression of KLF4 in mouse hair follicle stem cells
To examine if KLF4 is enriched in mouse epidermal stem cells,
we first purified these cells by fluorescent activated cell sorting
from the skin of 6-week-old wild-type C57BL/6 mice and
performed quantitative RT-PCR analysis. Antibodies against
CD34 and CD49f, two markers of skin bulge stem cells, were
used to enrich mouse skin bulge stem cells (CD34+/CD49f+ cells).
CD34, G protein coupled receptor expressed in follicles (FEX)
[39], gremlin, cysteine knot superfamily 1, BMP antagonist 1
(Cktsfb1), and dickkopf 3 (DDK3), highly expressed in CD34
enriched mouse keratinocyte stem cells, and KLF5 and bone
morphogenesis protein 4 (Bmp4), highly expressed in differentiat-
ed cells [4], were used as controls. As expected, significantly
Table 1. Primers for quantitative RT-PCR.
Sense Antisense
KLF4 59-GAAATTCGCCCGCTCCGATGA-39 59-CTGTGTGTTTGCGGTAGTGCC-39
GAPDH 59-TTCGACAGTCAGCCGCATCTTCTT-39 59-CAGGCGCCCAAYACGACCAAATC-39
CD34 59-TGGGTCAAGTTGTGGTGGGAA-39 59-GAAGAGGCGAGAGAGGAGAAATG-39
FEX 59-CACCGCTTGTATCATTTGTTCAGC-39 59-CATCCAACGAGTCTTCTCACTATG-39
Cktsfb1 59-TCCCATAGCCCATCCCTTTC-39 59-TCTGTCCCGTTTGCCATCAC-39
DKK 3 59-TACCTCTGAAAGCCAGTGCTCG-39 59-CTTGGTTGTGACTTCTCGGTGTG-39
Bmp4 59-GATTCCTGGTAACCGAATGC-39 59-GCAGCCCAAACATCTGTAGA-39
KLF5 59-GAGCTGGTCCAGACAAGATG-39 59-TGTCTTGATCTGTGTTACGC-39
doi:10.1371/journal.pone.0039663.t001
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decreased expression of KLF5 and Bmp4 were found in CD34+/
CD49f+ population when compared to those in CD34-/CD49f+
cells (Figure 1A, B). Importantly, KLF4 expression showed
a statistically significant increase in CD34+/CD49f+ population
(51.5% increase) compared to that in CD34-/CD49f+ cells.
Additional enrichment of bulge stem cells using CD34, CD49f,
and Lrig1 antibodies [9] revealed a more robust KLF4 expression
(.2 fold increase) in CD34+CD49f+Lrig1+ population when
compared to that in CD34+CD49f-Lrig1- cells (Figure 1C). To
further examine KLF4 expression in mouse hair follicle stem cells
in vivo, we generated a KLF4 promoter-driven EGFP (KLF4/
EGFP) transgenic mouse model (Figure S1). Flow cytometric
analysis showed that 12.3% of purified mouse dorsal keratinocytes
expressed both CD34 and CD49f (Figure 1D left), about 58% of
which were EGFP-positive (Figure 1D right).
KLF4-expressing cells possessed a label retaining
property
The label retention cell assay, a viable method used to locate
stem cells and to identify them as slow dividing, quiescent or
segregating chromosomes asymmetrically [40], was performed in
vivo. Three-day-old KLF4/EGFP mice were injected with BrdU
and left for an extended period (12 weeks) to label epidermal stem
cells as label-retaining cells (LRCs) compared with transit
amplifying cells in which the label was diluted after a prolonged
chase[41]. As shown in Figure 2A, 14.6% BrdU-positive cells were
observed in purified keratinocytes, and 4.1% of them were both
BrdU and KLF4/EGFP positive cells. The quiescent nature of
these cells was confirmed by lack of proliferation by immunohis-
tochemistry. KLF4 staining was colocalized with that of BrdU,
while proliferation was absent as indicted by negative staining of
Ki67, a proliferation marker (Figure 2B, red arrows).
Lineage tracing to show possible KLF4 expression in
mouse epidermal multipotent cells
Next we performed lineage tracing experiments, the most
convincing in vivo approach to demonstrate gene expression in
stem cells, using our tamoxifen-inducible KLF4 promoter-driven
Cre recombinase (KLF4/CreER
TM) transgenic mice [34] (Fig-
ure S1). After tamoxifen induction, KLF4-expressing cells and
their progenies were permanently labeled with b-galactosidase
(LacZ) and turned blue after X-gal staining in KLF4/CreER
TM
and Rosa26RLacZ double transgenic mice. 4 weeks after tamox-
ifen induction, LacZ-positive cells were observed in the possible
bulge area (Figure 3A and black arrows in Figure 3B, C) and IFE
(Figure 3B, C, red arrows). This observation was consistent with
previously proposed models regarding the position of stem and
progenitor cells [42,43]. The quiescent nature of possible bulge
stem cells was also shown by limited blue cells in this setting
(Figure S2). No blue cells were detected when KLF4/CreER
TM/
Rosa26RLacZ double transgenic mice were treated with vehicle
control or wild-type mice treated with tamoxifen (Figure 3D and
data not shown). Presence of blue cells in a typical structure of
epidermal proliferation unit (Figure 3E) also suggests a multipotent
and clonal nature of KLF4 expressing cells [44].
Knockout of KLF4 decreased stem cell population and
self-renewal potential
To evaluate the effect of KLF4 on mouse epidermal stem cells in
vivo, two stem cell markers CD34 and CD49f were used to detect
and sort keratinocytes from 6–8 week-old control (KLF4+/+) and
KLF4 knockout (KLF42/2) mice generated by induction of
KLF4/CreER
TM(+/2) and KLF4(flox+/+) double transgenic
mice with tamoxifen. While no obvious phenotypic changes of
mouse skin or hairs were observed eight weeks after tamoxifen
induction, we found that the number and the proliferation of hair
follicles were increased 45]. As shown in Figure 4A and 4B,
population of CD34+/CD49f+ cells decreased from
12.8%61.96% to 6.26%61.12% upon KLF4 knockout. To test
whether KLF4 knockout is associated with any defects of self-
renewal of stem cells, we used purified mouse dorsal skin
keratinocytes to perform colony-formation assay. As shown in
Figure 4C and D, 22 colonies were formed from 2000 wild type
keratinocytes. The colony number decreased to 9 from 2000
KLF4 knockout keratinocytes (P,0.05, n=3). This trend hold true
when the same number of sorted CD34+/CD49f+ cells was used
for the same assay (Figure 4C, E, P,0.05, n=3).
Figure 1. Expression of KLF4 in mouse hair follicle stem cells. (A
to C) Quantitative RT-PCR was performed to detect the expression of
KLF4, differentiation markers KLF5 and Bmp4 (A, C), and stem cells
markers CD34, FEX, Cktsfb1 and DDK3 (B) in different populations
isolated by FACS using anti-CD34, anti-CD49f, and anti-Lrig1 antibodies
in wild type mice, a procedure that was also described in D. 16106
sorted cells in each population were used. Values were expressed as
mean 6 SM of three independent experiments. *P,0.05 vs. control. (D)
The proportion of CD34+/CD49f+ cells (left) purified from 6-week-old
KLF4/EGFP mice was examined by flow cytometry. KLF4/EGFP-expres-
sing cells in CD34+/CD49f+ population were shown in the right panel.
Values in D were expressed as an average of three independent
experiments.
doi:10.1371/journal.pone.0039663.g001
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acute wound healing
KLF4 is critical for skin barrier formation [1]. To test the
hypothesis that KLF4 is important in maintaining skin integrity,
two full-thickness wounds in parallel were made in KLF4/Cre(+/
2)/KLF4(flox+/+) mice. As shown in Figure 5A, wounds started
to heal within 5 days in control mice (KLF4+/+). Wound closure
was observed 10 days after wound placement. However, in KLF4
knockout mice (KLF42/2), the healing process was significantly
delayed. To test the contribution of KLF4-expressing stem cells to
wound healing, lineage tracing was performed using KLF4/
CreER
TM/Rosa26RLacZ mice after tamoxifen induction. When
compared to the control (Figure 5B), 5 days after wound
placement, blue cells as indicated by black arrows were observed
in superbasal layer (inset 1) and around hair follicles (inset 2) in the
proximity of but outside the wound (Figure 5C). Ten days after the
wound placement, blue cells migrated inside the junction of the
wound and the adjacent normal tissue (green arrows in Figure 5D).
In addition, activation of KLF4-expressing epidermal multipotent
cells was shown by detection of blue cells upon wound placement
3 months and 8 months after tamoxifen induction of KLF4/
CreER
TM/Rosa26RLacZ mice (Figure S3). Furthermore, when
compared to the control (Figure 5E), it appears that migration of
blue cells towards the wound occurred from both hair follicles
(Figure 5F) and from epidermal suprabasal layer (Figure 5G).
Knockdown of KLF4 decreased the population of cancer
stem cells and cell migration in A431 cells
To further test the effect of KLF4 on maintenance of stem cells
and on stem cell-related cell migration, we first generated KLF4
knockdown stable cells by transduction with an established KLF4
shRNA, which specifically knocked down KLF4 with a high
efficiency [37], in A431 epidermoid carcinoma cells. Successful
KLF4 knockdown was shown by decreased mRNA and protein
levels of KLF4 and p21, one of KLF4 target genes, when
compared to that in control cells (Figure 6A, B). Previous work has
reported the podoplanin and CD44 double positive cells possess
cancer stem cell properties in A431 cell line [46]. We therefore
used these two markers to examine the effect of KLF4 knockdown
on this stem cell population. As expected, the proportion of
Figure 2. KLF4-expressing cells possessed label retaining
property. (A and B) 3-day-old KLF4/EGFP mice were injected with
BrdU (75mg/kg) for 5 consecutive days. BrdU-positive cells were
examined 3 months later by flow cytometry (A) and immunohisto-
chemical staining (B). Values of A were expressed as an average of three
independent experiments and results of B are representative of three
separate experiments. Anti-KLF4, anti-BrdU, and anti-Ki67 antibodies
were used to stain consecutive slides in B. Insets show enlarged portion
of the staining indicating co-localization of KLF4 and BrdU positive cells
with no Ki67 signals (red arrows). Scale bars, 50 mm.
doi:10.1371/journal.pone.0039663.g002
Figure 3. KLF4-expressing hair follicle stem cells were exam-
ined by lineage tracing. KLF4/CreER
TM/Rosa26RLacZ mice were
induced by tamoxifen (100mg/kg) for 5 consecutive days at 6-week-old.
4 weeks later X-gal staining was performed. Potential KLF4 expression
in interfollicular epidermis (shown by red arrows in B, C) and bulge area
(A, and black arrows in B, C) was shown. A typical epithelial proliferation
unit was shown in E (inset). Control staining was shown in D using
KLF4/CreER
TM/Rosa26RLacZ mice with mock induction. Representative
images were shown from 5 mice in each treatment group. Note that
fixation was performed without xylene in A and B. Scale bars, 80 mm.
doi:10.1371/journal.pone.0039663.g003
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(siCon cells) to 22% in KLF4 knockdown cells (siKLF4 cells)
(Figure 6C). Our mouse studies have shown that KLF4 was
important for wound healing, a process that involves keratinocyte
proliferation and migration. To test the effect of KLF4 on cell
migration in vitro, we used KLF4 knockdown A431 cells and
performed a scratch assay. 2610
6 cells were seeded into 6-well
plates and cultured to full confluence and then applied to this
assay. At 12 h after the scratch, the percentage of wound closure
for siCon cells was 40%, whereas siKLF4 cells only showed 12%
closure, indicating that KLF4 was essential for cell migration in
A431 cells (Figure 6D, E). Consistently, overexpression of KLF4 in
A431 cells increased cell migration accompanied by increased
cancer stem cell population by flow cytometric analysis using
podoplanin and CD 44 antibodies (Figure S4 and data not shown).
Discussion
KLF4 function in terminally differentiated epithelial cells of skin
includes regulation of the cell cycle, proliferation and differenti-
ation [47]. However, KLF4 expression and potential function in
epidermal stem cells has not been studied before. Here we utilized
6–8 week-old mice when hair follicles are in the resting (telogen)
phase in which follicles lie dormant without significant pro-
liferation, apoptosis or differentiation. Using the KLF4/EGFP
mouse model, we found that KLF4 was expressed in CD34+/
CD49f+ bulge stem cell-enriched populations (Figure 1D). The
quiescent nature of KLF4-expressing cells was also shown by co-
localization of KLF4 expressing cells with BrdU label retaining
cells (Figure 2A, B). We noticed that KLF4 gene expression in
CD34+/CD49f+/Lrig1+ cells was about 2.2 fold higher than in
CD34+/CD49f-/Lrig- cells sorted from wild-type mice. High
Figure 4. Knockout of KLF4 decreased hair follicle stem cell population and self-renewal potential. (A) Dorsal skin keratinocytes isolated
from control (KLF4+/+) and KLF4 knockout (KLF42/2) mice were analyzed by flow cytometry using mouse epidermal stem cell markers CD34 and
CD49f. B. Quantification of data from A was presented. Values were expressed as mean 6 SM of three independent experiments. *P,0.05 vs. control.
(C) Colony formation assay was performed using total dorsal skin keratinocytes (top) or sorted CD34+/CD49f+ cells (bottom) from control (left) and
KLF4 knockout (right) mice. Typical images were shown from three separate experiments. (D and E) Quantitation of the colony numbers from 2000
seeded keratinocytes in (C). Data shown were the mean 6 SM of three separate experiments. *P,0.05 vs. control. Scale bars, 1 cm.
doi:10.1371/journal.pone.0039663.g004
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epithelial cells [48] and low percentage of skin epidermal stem cells
may be a reason why a bigger difference has not been observed.
Nevertheless, our studies collectively provide the first evidence that
KLF4 was likely expressed in mouse hair follicle stem cells,
especially in bulge stem cells.
We found that the proportion of KLF4-positive cells in LRCs
was 4.1%, suggesting that only a subset of these LRCs expressed
KLF4. These results reveal a heterogeneous nature of LRCs.
Different nature of KLF4-expressing and KLF4-non-expressing
LRCs and the related functional influence in wound healing are
currently unknown. Our studies also showed that KLF4 knockout
decreased the population of CD34+/CD49f+ cells accompanied
by reduced self-renewal ability of these cells. Together with the
label retaining ability of KLF4 expressing cells, our results
indicated KLF4 plays an important role in the homeostasis of
skin bulge stem cells. In addition, expression of KLF4 in rare skin
stem cells and in the bulk of differentiated keratinocytes may
suggest that the functions of KLF4 in these populations are
different. Alternatively but not mutually exclusively, different
KLF4 isoforms may exist to deliver different functions as recently
reported in pancreatic cancer cells [49]. Characterization of
different KLF4 isoforms and/or separation of distinct KLF4
expressing cells will be necessary for dissecting specific functions of
KLF4 in skin homeostasis as well as pathogenesis including wound
healing.
Previous work has demonstrated that stem cells located in the
bulge area [12] and isthmus [50] contributed to wound healing.
Here we showed that KLF4-expressing multipotent cells partici-
pated in re-epithelialization during cutaneous wound healing. It is
Figure 5. KLF4-expressing multipotent cells contributed to cutaneous wound healing. (A) KLF4 knockout was induced as described in
Material and Methods. Pictures were taken 1, 5, and 10 days after two parallel 8mm wounds were placed into backs of the mice. Note that the left
wounds were introduced first, and they appeared severer than the right ones because of physical stretch. (B to G) 5mm wounds were introduced into
the backs of KLF4/CreER
TM/Rosa26RLacZ mice 5 (B, C) or 10 days (D–G) after using control (B, E) or tamoxifen (C, D, F, G) induction and X-gal staining
was performed. Blue strips on epidermis were shown in C (inset 1) and G. Blue cells was indicated by black arrows outside (C) and by green arrows
inside (D) the conjunction of the wound (separated by dashed green lines). Inset 2 in C showed blue cells around hair follicles. Migration of KLF4
expressing multipotent cells from hair follicles (F) and interfollicular epidermis towards the wound area was detected similarly. Results shown are
representative of three independent experiments. Scale bars, 80 mm.
doi:10.1371/journal.pone.0039663.g005
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follicle stem cell contribution at the cost of delayed reepithelializa-
tion [51]. From our study, KLF4 expression in possible hair follicle
stem cells may contribute to the wound healing (Figure 5). We also
noticed that KLF4-expressing stem cells remained quiescent as
evidenced by rarely detectable blue cells eight months after the
cells were labeled (Figure S3E). However, they were readily
activated and detectable by wound placement (Figure S3F). This
observation is consistent with a recent proposal for olfactory neural
stem cells, stem cells within the LRC population, when present,
may represent a reserve population activated after tissue damage,
whereas under normal conditions, a cycling population of stem
cells maintains homeostasis[52]. Moreover, KLF4 deficiency
delayed the process of wound healing and cell migration. It has
been reported that KLF4 is required for establishing skin barrier
function as evidenced by KLF4 deficiency selectively perturbing
the differentiation of the late-stage structures such as cornified
envelope ENREF[1]. It is not clear whether the role of KLF4 in
barrier function is also involved in wound healing in our setting.
Finally, our wound healing model did not limit for contraction.
Although this simple method allowed us to observe an obvious
phenotype, more rigorous models should be used in the future in
order to define the role of KLF4 in the complex wound healing
process. For example, an early inflammation model [53] and other
surgical models including pressure ulcer model and mechanical
load model with limit for contraction could be used [54].
Nonetheless, our results suggest a critical function of KLF4-
Figure 6. KLF4 knockdown decreased the population of cancer stem cells and cell migration in A431 cells. (A) KLF4 expression was
examined in control (siCon) and KLF4 knockdown (siKLF4) cells by real time PCR. *P,0.05 vs. control. (B) Down regulation of KLF4 was accompanied
by reduced expression of its downstream target p21 by Western Blotting analysis (Left) and the corresponding densitometry quantification (Right).
(C) Flow cytometric analysis of cancer stem cells using CD44 and podoplanin as the markers in siCon and siKLF4 cells. Values were expressed as an
average of three independent experiments. (D) Scratch assays were performed using siCon and siKLF4 cells. 2610
6 cells were cultured to confluence,
then scratched and photographed immediately (0 h) or after 12 hours (12 h). (E) Quantification of cell migration during 12 h after scratching. Error
bars represent standard error from three separate experiments. *P,0.05 vs. control.
doi:10.1371/journal.pone.0039663.g006
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healing.
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